Drug administration may cause disturbance of the gut
microbiota. It is believed that antibiotics can affect the intestinal
microfloral balance and allow naturally opportunistic organisms to grow and
multiply. Antibiotic therapy produces some side effects in the host, including
disturbance of the metabolism and absorption of vitamins, alteration of
susceptibility to infections and overgrowth of yeast and/or Clostridium
difficile.
Azithromycin (deoxo-azamethyl-homo-erythromycin, AZM) is the most
widely used synthetic analogue having antimicrobiological properties. It is
active against a wide number of pathogens including Streptococci, Staphylococcus
aureus, Propionibacterium acnes, Listeria monocytogenes, Haemophilus
influenzae, Neisseria gonorrhoeae, Mycobacterium avium, and Chlamydia
trachomatis. AZM belongs to the macrolide antibiotics and is currently
widely used in the treatment of cystic fibrosis patients. It is currently
recommended as chronic therapy for cystic fibrosis patients infected with Pseudomonas
aeruginosa. Long-term administration of AZM helps to reduce or stabilize
clinical symptoms of airway inflammation in patients chronically infected with P.
aeruginosa. Some side effects are associated with this macrolide therapy.
One study has reported a significant increase in mild adverse effects
(wheezing, diarrhea and nausea) in patients receiving azithromycin.
Comments
Post a Comment